vs

Side-by-side financial comparison of Natera, Inc. (NTRA) and Real Brokerage Inc (REAX). Click either name above to swap in a different company.

Natera, Inc. is the larger business by last-quarter revenue ($665.5M vs $568.5M, roughly 1.2× Real Brokerage Inc). Natera, Inc. runs the higher net margin — 7.1% vs -0.1%, a 7.2% gap on every dollar of revenue. On growth, Real Brokerage Inc posted the faster year-over-year revenue change (52.6% vs 39.8%). Natera, Inc. produced more free cash flow last quarter ($37.8M vs $8.4M).

Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...

Anywhere Real Estate Inc., formerly Realogy, was an American real estate services firm. It operated and franchised real estate brands that provided brokerage, relocation, title, insurance, and settlement services. Brands included Better Homes and Gardens Real Estate, Century 21 Real Estate, Coldwell Banker, Corcoran Group, ERA Real Estate and Sotheby's International Realty. In 2026, the company was acquired by Compass, Inc.

NTRA vs REAX — Head-to-Head

Bigger by revenue
NTRA
NTRA
1.2× larger
NTRA
$665.5M
$568.5M
REAX
Growing faster (revenue YoY)
REAX
REAX
+12.8% gap
REAX
52.6%
39.8%
NTRA
Higher net margin
NTRA
NTRA
7.2% more per $
NTRA
7.1%
-0.1%
REAX
More free cash flow
NTRA
NTRA
$29.4M more FCF
NTRA
$37.8M
$8.4M
REAX

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
NTRA
NTRA
REAX
REAX
Revenue
$665.5M
$568.5M
Net Profit
$47.3M
$-447.0K
Gross Margin
7.9%
Operating Margin
-3.4%
-0.1%
Net Margin
7.1%
-0.1%
Revenue YoY
39.8%
52.6%
Net Profit YoY
187.9%
82.7%
EPS (diluted)
$0.36
$0.00

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NTRA
NTRA
REAX
REAX
Q4 25
$665.5M
Q3 25
$592.2M
$568.5M
Q2 25
$546.6M
$540.7M
Q1 25
$501.8M
$354.0M
Q4 24
$476.1M
Q3 24
$439.8M
$372.5M
Q2 24
$413.4M
Q1 24
$367.7M
$200.7M
Net Profit
NTRA
NTRA
REAX
REAX
Q4 25
$47.3M
Q3 25
$-87.5M
$-447.0K
Q2 25
$-100.9M
$1.5M
Q1 25
$-66.9M
$-5.0M
Q4 24
$-53.8M
Q3 24
$-31.6M
$-2.6M
Q2 24
$-37.5M
Q1 24
$-67.6M
$-16.1M
Gross Margin
NTRA
NTRA
REAX
REAX
Q4 25
Q3 25
7.9%
Q2 25
8.9%
Q1 25
9.6%
Q4 24
Q3 24
8.6%
Q2 24
Q1 24
10.3%
Operating Margin
NTRA
NTRA
REAX
REAX
Q4 25
-3.4%
Q3 25
-16.5%
-0.1%
Q2 25
-20.2%
0.3%
Q1 25
-15.8%
-1.5%
Q4 24
-13.6%
Q3 24
-8.9%
-0.7%
Q2 24
-10.6%
Q1 24
-20.2%
-7.8%
Net Margin
NTRA
NTRA
REAX
REAX
Q4 25
7.1%
Q3 25
-14.8%
-0.1%
Q2 25
-18.5%
0.3%
Q1 25
-13.3%
-1.4%
Q4 24
-11.3%
Q3 24
-7.2%
-0.7%
Q2 24
-9.1%
Q1 24
-18.4%
-8.0%
EPS (diluted)
NTRA
NTRA
REAX
REAX
Q4 25
$0.36
Q3 25
$-0.64
$0.00
Q2 25
$-0.74
$0.01
Q1 25
$-0.50
$-0.02
Q4 24
$-0.41
Q3 24
$-0.26
$-0.01
Q2 24
$-0.30
Q1 24
$-0.56
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NTRA
NTRA
REAX
REAX
Cash + ST InvestmentsLiquidity on hand
$38.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$1.7B
$53.6M
Total Assets
$2.4B
$145.2M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NTRA
NTRA
REAX
REAX
Q4 25
Q3 25
$1.0M
$38.7M
Q2 25
$16.0M
$49.7M
Q1 25
$17.8M
$24.7M
Q4 24
$22.7M
Q3 24
$29.5M
$22.6M
Q2 24
$90.3M
Q1 24
$69.1M
$20.1M
Stockholders' Equity
NTRA
NTRA
REAX
REAX
Q4 25
$1.7B
Q3 25
$1.3B
$53.6M
Q2 25
$1.2B
$49.2M
Q1 25
$1.2B
$32.8M
Q4 24
$1.2B
Q3 24
$878.5M
$29.8M
Q2 24
$836.5M
Q1 24
$794.1M
$25.6M
Total Assets
NTRA
NTRA
REAX
REAX
Q4 25
$2.4B
Q3 25
$1.8B
$145.2M
Q2 25
$1.8B
$149.4M
Q1 25
$1.7B
$100.5M
Q4 24
$1.7B
Q3 24
$1.6B
$102.5M
Q2 24
$1.5B
Q1 24
$1.5B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NTRA
NTRA
REAX
REAX
Operating Cash FlowLast quarter
$73.9M
$8.8M
Free Cash FlowOCF − Capex
$37.8M
$8.4M
FCF MarginFCF / Revenue
5.7%
1.5%
Capex IntensityCapex / Revenue
5.4%
0.1%
Cash ConversionOCF / Net Profit
1.56×
TTM Free Cash FlowTrailing 4 quarters
$109.1M
$71.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NTRA
NTRA
REAX
REAX
Q4 25
$73.9M
Q3 25
$59.4M
$8.8M
Q2 25
$37.6M
$41.0M
Q1 25
$44.5M
$15.9M
Q4 24
$52.9M
Q3 24
$51.8M
$7.2M
Q2 24
$4.0M
Q1 24
$27.0M
$21.5M
Free Cash Flow
NTRA
NTRA
REAX
REAX
Q4 25
$37.8M
Q3 25
$37.0M
$8.4M
Q2 25
$11.7M
$40.8M
Q1 25
$22.6M
$15.7M
Q4 24
$34.8M
Q3 24
$35.5M
$6.8M
Q2 24
$-7.7M
Q1 24
$6.7M
$21.4M
FCF Margin
NTRA
NTRA
REAX
REAX
Q4 25
5.7%
Q3 25
6.2%
1.5%
Q2 25
2.1%
7.5%
Q1 25
4.5%
4.4%
Q4 24
7.3%
Q3 24
8.1%
1.8%
Q2 24
-1.9%
Q1 24
1.8%
10.7%
Capex Intensity
NTRA
NTRA
REAX
REAX
Q4 25
5.4%
Q3 25
3.8%
0.1%
Q2 25
4.7%
0.0%
Q1 25
4.3%
0.1%
Q4 24
3.8%
Q3 24
3.7%
0.1%
Q2 24
2.8%
Q1 24
5.5%
0.0%
Cash Conversion
NTRA
NTRA
REAX
REAX
Q4 25
1.56×
Q3 25
Q2 25
27.13×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons